Written by Private MD Labs Medical Writing Team • Last Updated: September 8, 2025
Juvenile Idiopathic Arthritis (JIA) is a chronic condition causing joint inflammation in children under 16 years of age. While there is no single blood test that can definitively diagnose JIA, laboratory testing plays a fundamental role in assessing inflammation levels, identifying genetic risk factors, and supporting the diagnostic process alongside clinical examination.
This test measures IL-6 levels, which are often elevated in the serum of patients with Juvenile Idiopathic Arthritis. High IL-6 levels indicate active inflammation and play a crucial role in understanding the disease's pathogenesis, helping healthcare providers monitor disease activity and treatment response.
Blood tests are essential for monitoring the inflammatory response associated with JIA, identifying specific biomarkers that may be present in certain subtypes of the condition, and assessing genetic predisposition. These tests help healthcare providers develop appropriate treatment plans and monitor the body's response to therapy.
This genetic test identifies specific HLA-DRB1 alleles, particularly HLA-DRB1*08, which have been associated with an increased risk of developing juvenile idiopathic arthritis. Testing for these genetic markers can help predict susceptibility to the disease and provide valuable information for family counseling.
This test detects CCP antibodies that can be present in some cases of Juvenile Idiopathic Arthritis. While these antibodies are more commonly associated with adult rheumatoid arthritis, their presence in children can help classify specific subtypes of JIA and guide treatment decisions.
This comprehensive genetic test provides detailed analysis of multiple HLA alleles, including HLA-DRB1*11 and HLA-DRB1*08, which are associated with increased risk of developing juvenile idiopathic arthritis. This high-resolution testing offers more precise genetic profiling for risk assessment and disease susceptibility.
These laboratory tests provide valuable information about inflammation levels, genetic predisposition, and specific biomarkers associated with JIA. Results should always be interpreted by a qualified healthcare provider who can correlate findings with clinical symptoms and physical examination to make an accurate diagnosis and develop an appropriate treatment plan.
The information here is for educational purposes only and is not a substitute for professional medical advice. Always consult with a healthcare provider for diagnosis and treatment of juvenile idiopathic arthritis.